Movement Disorders in Metabolic Disorders.

Abnormal movements Electrolytes Internal medicine Metabolic disorders Movement disorders

Journal

Current neurology and neuroscience reports
ISSN: 1534-6293
Titre abrégé: Curr Neurol Neurosci Rep
Pays: United States
ID NLM: 100931790

Informations de publication

Date de publication:
09 02 2019
Historique:
entrez: 11 2 2019
pubmed: 11 2 2019
medline: 7 1 2020
Statut: epublish

Résumé

We provide a review of the movement disorders that complicate selected metabolic disorders, including the abnormal movements that may appear during or after their treatment. Movement disorders may be underrecognized when arising in the context of a broad range of metabolic disorders. Abnormal movements may occur as the initial manifestation of a systemic disease, at any time during its course, or as a result of the medical interventions required for its management. Ascertaining movement phenomenology in acute and subacute presentations may assist in the determination of the specific underlying metabolic disorder. The management of movement disorders associated with metabolic disorders depends on the underlying pathophysiology.

Identifiants

pubmed: 30739241
doi: 10.1007/s11910-019-0921-3
pii: 10.1007/s11910-019-0921-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7

Références

N Engl J Med. 2010 Oct 21;363(17):e27
pubmed: 20961240
Parkinsonism Relat Disord. 2002 Dec;9(2):117-9
pubmed: 12473403
BMJ Case Rep. 2013 Jun 18;2013:
pubmed: 23780767
Am J Kidney Dis. 2014 Feb;63(2):286-8
pubmed: 24183109
Neurol Clin. 2017 Nov;35(4):601-611
pubmed: 28962803
Eur J Neurol. 2010 Dec;17(12):1463-70
pubmed: 20491897
Ann Neurol. 1989 Sep;26(3):415
pubmed: 2802542
Mov Disord. 2006 Jul;21(7):1054-5
pubmed: 16615065
Parkinsonism Relat Disord. 2005 Aug;11(5):331-2
pubmed: 15970453
Neurol Clin. 2006 Feb;24(1):123-32
pubmed: 16443134
Parkinsonism Relat Disord. 2018 Oct;55:141-142
pubmed: 29887356
Mov Disord. 2010 May 15;25(7):966-8
pubmed: 20461820
JAMA Neurol. 2018 Jul 1;75(7):888-889
pubmed: 29799978
Mov Disord. 2000 Nov;15(6):1273-6
pubmed: 11104223
BMC Neurol. 2018 May 7;18(1):62
pubmed: 29734949
Resuscitation. 2017 Jun;115:169-172
pubmed: 28342959
Mov Disord. 2002 Mar;17(2):415-9
pubmed: 11921137
J Clin Anesth. 2017 Feb;36:59-61
pubmed: 28183575
Neurol Sci. 2006 Dec;27(6):439-41
pubmed: 17205232
Neuroradiol J. 2014 Jun;27(3):288-92
pubmed: 24976195
Brain. 1963 Mar;86:111-36
pubmed: 13928398
Eur Neurol. 1984;23(1):26-33
pubmed: 6370700
Parkinsonism Relat Disord. 2004 Aug;10(6):381-3
pubmed: 15261881
J Neurol Neurosurg Psychiatry. 1975 Aug;38(8):729-39
pubmed: 1185193
Eur J Neurol. 2014 Dec;21(12):1443-50
pubmed: 25220878
Brain. 2004 Oct;127(Pt 10):2173-82
pubmed: 15364701
Handb Clin Neurol. 2018;147:307-317
pubmed: 29325620
J Neurol Neurosurg Psychiatry. 1994 Jun;57(6):748-50
pubmed: 8006661
Semin Neurol. 2011 Apr;31(2):139-43
pubmed: 21590619
Ann Neurol. 1994 Feb;35(2):239-43
pubmed: 8109907
Mov Disord. 1998 Jul;13(4):746-8
pubmed: 9686786
Endocr Pract. 2005 Jul-Aug;11(4):259-64
pubmed: 16006304
Handb Clin Neurol. 2016;136:957-69
pubmed: 27430452
Parkinsonism Relat Disord. 2011 Dec;17(10):771-3
pubmed: 21733736
Pract Neurol. 2017 Jan;17(1):60-62
pubmed: 27807107
Neurology. 2008 Apr 15;70(16 Pt 2):1497-8
pubmed: 18413576
Korean J Anesthesiol. 2013 Oct;65(4):341-4
pubmed: 24228149
Eur J Paediatr Neurol. 2011 Sep;15(5):390-404
pubmed: 21835657
Arch Neurol. 2005 Sep;62(9):1385-90
pubmed: 16157745
Parkinsonism Relat Disord. 2013 Aug;19(8):709-16
pubmed: 23660544
J Neuroimaging. 2015 Mar-Apr;25(2):319-324
pubmed: 24612187
Ann Pharmacother. 1999 Jan;33(1):86-92
pubmed: 9972388
Am J Emerg Med. 2009 Mar;27(3):369.e1-369.e3
pubmed: 19328390
Parkinsonism Relat Disord. 2006 Mar;12(2):93-6
pubmed: 16256408
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):136-7
pubmed: 11118272
Neurobiol Dis. 2012 Apr;46(1):1-18
pubmed: 22266337
J Neurol. 2009 Mar;256(3):320-32
pubmed: 19224314
Mov Disord. 2012 Jul;27(8):935-46
pubmed: 22555904
J Neurol. 2004 Jul;251(7):849-52
pubmed: 15258788
Neurol Clin. 2002 Feb;20(1):227-39, vii
pubmed: 11754308
Am J Hum Genet. 2008 Mar;82(3):673-84
pubmed: 18308289
Neurol Clin. 2015 Feb;33(1):269-97
pubmed: 25432733
Mov Disord. 1993 Jul;8(3):398-400
pubmed: 8341314
Neurol Sci. 2014 Dec;35(12):1851-5
pubmed: 25262066
J Neurol. 2009 Dec;256(12):2106-8
pubmed: 19763382
Mov Disord. 2015 Feb;30(2):198-205
pubmed: 24919927
Neurol Sci. 2019 Jan;40(1):133-138
pubmed: 30324251
J Neurol. 1985;232(2):109-11
pubmed: 4020389
Medicine (Baltimore). 2017 Mar;96(11):e6312
pubmed: 28296742

Auteurs

José Luiz Pedroso (JL)

Division of General Neurology and Ataxia Unit, Department of Neurology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Orlando G Barsottini (OG)

Division of General Neurology and Ataxia Unit, Department of Neurology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Alberto J Espay (AJ)

Gardner Neuroscience Institute, Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, OH, USA. aespay@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH